Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Rosseti Urals reported for 3 months of 2025 by RAS
5/5/25
MRKU
Board of Directors of Far-Eastern Energy Company recommended that dividends be paid for 2024
5/5/25
DVEC
JSFC Sistema has transferred control over Voskhod
5/5/25
AFKS
Buryatzoloto reported for 2024 by IFRS
5/1/25
BRZL
Globaltrack reported for 3 months of 2025 by RAS
5/1/25
GTRK
Rosinter reported for 2024 by IFRS
5/1/25
ROST
Rosinter reported for 2024 by RAS
5/1/25
ROST
Rosinter reported for 3 months of 2025 by RAS
5/1/25
ROST
YATEK reported for 3 months of 2025 by RAS
5/1/25
YAKG
Primorye Bank reported for 2024 by RAS
4/30/25
PRMB
«
Previous
12
13
14
15
16
17
18
19
20
21
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 